Exhibit 16.1
November 1, 2019
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by Orchard Therapeutics plc pursuant to Item 5 of FormF-3 (copy attached), which we understand will be filed with the Securities and Exchange Commission as part of the Registration Statement on FormF-3dated November 1, 2019. We agree with the statements concerning our Firm contained therein.
Very truly yours, |
/s/ PricewaterhouseCoopers LLP |
Reading |
United Kingdom |
Attachment |
PricewaterhouseCoopers LLP, 3 Forbury Place, 23 Forbury Road, Reading, Berkshire, RG1 3JH
T: +44 (0) 118 597 111, F: +44 (0) 1189 383 020, www.pwc.co.uk
PricewaterhouseCoopers LLP is a limited liability partnership registered in England with registered number OC303525. The registered office of PricewaterhouseCoopers LLP is 1 Embankment Place, London WC2N 6RH. PricewaterhouseCoopers LLP is authorised and regulated by the Financial Conduct Authority for designated investment business.